Artiva Biotherapeutics, Inc. (ARTV)

Artiva Biotherapeutics Statistics

Total Valuation

ARTV has a market cap or net worth of $382.39 million. The enterprise value is $305.87 million.

Market Cap	382.39M
Enterprise Value	305.87M

Important Dates

The last earnings date was Friday, May 8, 2026, before market open.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

ARTV has 48.59 million shares outstanding. The number of shares has increased by 43.09% in one year.

Current Share Class	48.59M
Shares Outstanding	48.59M
Shares Change (YoY)	+43.09%
Shares Change (QoQ)	+0.43%
Owned by Insiders (%)	4.51%
Owned by Institutions (%)	14.32%
Float	22.86M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.21
P/TBV Ratio	4.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.16, with a Debt / Equity ratio of 0.12.

Current Ratio	8.16
Quick Ratio	7.98
Debt / Equity	0.12
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -67.86% and return on invested capital (ROIC) is -40.97%.

Return on Equity (ROE)	-67.86%
Return on Assets (ROA)	-38.72%
Return on Invested Capital (ROIC)	-40.97%
Return on Capital Employed (ROCE)	-96.84%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	-$837,212
Employee Count	104
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +293.50% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+293.50%
50-Day Moving Average	8.59
200-Day Moving Average	5.03
Relative Strength Index (RSI)	39.58
Average Volume (20 Days)	651,476

Short Selling Information

The latest short interest is 229,817, so 0.47% of the outstanding shares have been sold short.

Short Interest	229,817
Short Previous Month	148,487
Short % of Shares Out	0.47%
Short % of Float	1.01%
Short Ratio (days to cover)	0.67

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-92.07M
Pretax Income	-87.07M
Net Income	-87.07M
EBITDA	-89.43M
EBIT	-92.07M
Earnings Per Share (EPS)	-$3.55

Balance Sheet

The company has $86.78 million in cash and $10.26 million in debt, with a net cash position of $76.52 million or $1.57 per share.

Cash & Cash Equivalents	86.78M
Total Debt	10.26M
Net Cash	76.52M
Net Cash Per Share	$1.57
Equity (Book Value)	87.85M
Book Value Per Share	3.55
Working Capital	77.86M

Cash Flow

In the last 12 months, operating cash flow was -$77.86 million and capital expenditures -$2.32 million, giving a free cash flow of -$80.18 million.

Operating Cash Flow	-77.86M
Capital Expenditures	-2.32M
Depreciation & Amortization	2.64M
Net Borrowing	-132,000
Free Cash Flow	-80.18M
FCF Per Share	-$1.65

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ARTV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-43.09%
Shareholder Yield	-43.09%
Earnings Yield	-22.77%
FCF Yield	-20.97%

Analyst Forecast

The average price target for ARTV is $35.80, which is 354.89% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$35.80
Price Target Difference	354.89%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1